(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

As we mark a decade of the Forbes 30 Under 30 Asia list, here’s a look at some of its most successful members to date.

Law firms may want to rethink the pivot from Hong Kong to the U.S., given Trump’s tariffs have made way for a potential thaw ...

World’s largest maker of electric-vehicle batteries could expand its IPO deal to as much as US$5.3 billion if several upsize options are exercised.

eToro is planning to raise around $620 million in an upsized U.S. initial public offering (IPO) priced above market range, the company said on Tuesday. The stock and cryptocurrency trading platform ...

Charming Medical, which provides therapies and products inspired by traditional Chinese medicine, filed for an initial public offering of 1.6 million shares. The company said in a filing with the ...

Pony AI Inc has confidentially filed for Hong Kong IPO to raise capital for expansion. Its stock surged and caught fire for ...

Robinhood rival EToro Group raised nearly $620 million in its IPO. Meanwhile, Ryan Reynolds's MNTN is considering launching ...

In Q1 2025, the good performance of Swire Properties' retail properties was offset by the poor results for its office assets.

Chinese mining company Zijin Mining plans to spin off its gold business and list it on the Hong Kong stock exchange, with ...

Chinese internet giant Tencent on Wednesday reported a better-than-expected increase in first-quarter revenue, propelled by ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.